News
One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...
TechCentral’s guests in this episode of the Show believe Blue Label Telecoms and Cell C present a compelling investment case.
Blue Label has clarified that TPC can acquire an additional 13.66% in Cell C from the SPVs in settlement of outstanding loans. However, any further acquisition would require Competition Commission ...
A new avenue for targeted drug delivery has been proposed by researchers from The Grainger College of Engineering at the ...
Blue Label Telecoms has said it may list mobile operator Cell C on the JSE as part of a broader restructuring of the group.
15d
ITWeb on MSNBlue Label considers listing Cell C on JSEThe firm’s proposed restructure will assist in facilitating a separation and potential future listing of Cell C on the ...
Imagine looking at thousands of scattered puzzle pieces and trying to guess what picture they create. Without any reference ...
Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world's deadliest pathogen. This labeling could lead to simpler, faster TB tests.
Johannesburg - Blue Label Telecoms [JSE:BLU] has said that plans to acquire 35% of Cell C for R4bn as part of a recapitalisation plan are still “on track”. In December last year, the boards of Cell C ...
Blue Label’s financial results revealed that Cell C remains technically insolvent, with its liabilities continuing to exceed its assets — a condition that has persisted since shortly after 2019.
Blue Label is exploring a potential restructure of the group which may facilitate separation and potential future listing of Cell C on the Prime Segment of the Main Board of the Johannesburg Stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results